High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome.
| Autor: | Feller, N, Schuurhuis, G J, van der Pol, M A, Westra, G, Weijers, G W D, van Stijn, A, Huijgens, P C, Ossenkoppele, G J |
|---|---|
| Zdroj: | Leukemia (08876924). Jan2003, Vol. 17 Issue 1, p68. 8p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|